🔎 Trials Near Me

Domov › Areata alopecija › Texas

Klinične študije za Areata alopecija v Texas

7 študij za Areata alopecija išče udeležence na lokacijah v Texas.

Mesta v Texas

Uradno besedilo študije (angleško)

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

  • 3A Research - East location /ID# 283404, El Paso
  • Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07772492

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

  • Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
Vključevanje udeležencevFaza 2
Starost 18–50 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07533006

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  • The University of Texas Health Science Center at Houston, Bellaire
  • Center for Clinical Studies, Houston
  • Center for Clinical Studies - Clear Lake, Webster
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06873945

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

  • Center for Clinical Studies, LTD. LLP, Houston
  • Texas Dermatology and Laser Specialists, San Antonio
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07733765

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

  • Arlington Research Center, Inc /ID# 258028, Arlington
  • Bellaire Dermatology Associates /ID# 259360, Bellaire
  • Dfw Clinical Trials /ID# 284604, Carrollton
  • in še 5
Vključevanje udeležencevFaza 3
Starost 12–63 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06012240

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

  • 3A Research, El Paso
  • Texas Dermatology and Laser Specialists, San Antonio
Vključevanje udeležencevFaza 3
Starost 6–14 · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT07029828

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  • Dermatology Treatment And Research Center - Dallas, Dallas
  • North Texas Center For Clinical Research, Frisco
  • Austin Institute For Clinical Research Inc., Pflugerville
  • in še 1
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT07133308

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.